These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7176217)

  • 21. The effect of 6-amidino-2-naphtyl-4-guanidinobenzoate dimethane sulfonate (FUT-175) on experimental glomerulonephritis in mice.
    Nagai H; Yamada H; Matsuura N; Inagaki N; Shimazawa T; Koda A
    Jpn J Pharmacol; 1984 May; 35(1):55-60. PubMed ID: 6471619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of the antiplatelet agents ticlopidine and dipyridamole on experimental immune complex glomerulonephritis in rats.
    Izumino K; Iida H; Asaka M; Mizumura Y; Sasayama S
    Nephron; 1986; 43(1):56-61. PubMed ID: 2939358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific increases in urinary excretion of anti-DNA antibodies in lupus mice induced by lysozyme administration: further evidence for DNA-anti-DNA immune complexes in the pathogenesis of nephritis.
    Yamamoto T; Nagase M; Hishida A; Honda N
    Clin Exp Immunol; 1993 Jan; 91(1):115-20. PubMed ID: 8419071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of the anticomplementary agent, K-76 monocarboxylic acid, on experimental immune complex glomerulonephritis in rats.
    Iida H; Izumino K; Asaka M; Takata M; Mizumura Y; Sasayama S
    Clin Exp Immunol; 1987 Jan; 67(1):130-4. PubMed ID: 3497741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flare-up of antigen-induced arthritis in mice after challenge with intravenous antigen: effects of pre-treatment with cobra venom factor and anti-lymphocyte serum.
    Lens JW; van den Berg WB; van de Putte LB; Berden JH; Lems SP
    Clin Exp Immunol; 1984 Sep; 57(3):520-8. PubMed ID: 6235993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EXPERIMENTAL GLOMERULONEPHRITIS. IV. PARTICIPATION OF COMPLEMENT IN NEPHROTOXIC NEPHRITIS.
    UNANUE E; DIXON FJ
    J Exp Med; 1964 Jan; 119(6):965-82. PubMed ID: 14176294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An evaluation of the role of complement depletion in experimental membranous nephropathy in the rat.
    Gabbai FB; Mundy CA; Wilson CB; Blantz RC
    Lab Invest; 1988 May; 58(5):539-48. PubMed ID: 3367636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complement-mediated killing of mesangial cells in experimental glomerulonephritis: cell death by a combination of apoptosis and necrosis.
    Shimizu A; Masuda Y; Kitamura H; Ishizaki M; Ohashi R; Sugisaki Y; Yamanaka N
    Nephron; 2000 Oct; 86(2):152-60. PubMed ID: 11014985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of terminal complement components in experimental immune glomerular injury.
    Adler S; Baker PJ; Pritzl P; Couser WG
    Kidney Int; 1984 Dec; 26(6):830-7. PubMed ID: 6241952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acceleration of glomerulonephritis in NZB x NZW mice by early immunization with DNA and injection of bacterial lipopolysaccharide. Experimental approach to the treatment of lupus nephritis by use of the accelerated model of NZB x NZW mouse disease.
    Fournie GJ; Minh MG; Mignon-Conte MA; Hass S; Lambert PH; Conte JJ
    J Clin Lab Immunol; 1980 Sep; 4(2):103-6. PubMed ID: 7441709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of IgG rheumatoid factor (RF) production by antibody-antibody (RF-like) immune complexes: the role of T cells, complement and Fc gamma receptors.
    Nordström E; Möller E; Abedi-Valugerdi M
    J Autoimmun; 1998 Apr; 11(2):131-40. PubMed ID: 9650092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5.
    Wang Y; Hu Q; Madri JA; Rollins SA; Chodera A; Matis LA
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8563-8. PubMed ID: 8710910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel therapeutic approach by culture filtrate of Cryptococcus neoformans var. gattii (CneF) in experimental immune complex glomerulonephritis.
    Mirshafiey A; Mehrabian F; Razavi A; Shidfar MR; Namaki S
    Gen Pharmacol; 2000 May; 34(5):311-9. PubMed ID: 11368886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization.
    Rudofsky UH; Evans BD; Balaban SL; Mottironi VD; Gabrielsen AE
    Lab Invest; 1993 Apr; 68(4):419-26. PubMed ID: 8479150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dietary fat and immune function. II. Effects on immune complex nephritis in (NZB x NZW)F1 mice.
    Yumura W; Hattori S; Morrow WJ; Mayes DC; Levy JA; Shirai T
    J Immunol; 1985 Dec; 135(6):3864-8. PubMed ID: 2933453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice.
    Moser K; Kalies K; Szyska M; Humrich JY; Amann K; Manz RA
    Arthritis Rheum; 2012 Apr; 64(4):1237-46. PubMed ID: 22006377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of NZB/NZW murine nephritis by administration of a syngeneic monoclonal antibody to DNA. Possible role of anti-idiotypic antibodies.
    Hahn BH; Ebling FM
    J Clin Invest; 1983 Jun; 71(6):1728-36. PubMed ID: 6223048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Role of complement in experimental glomerulonephritis].
    Parra Borges G; Mosquera J; Rodríguez-Iturbe B
    Invest Clin; 1991; 32(2):91-105. PubMed ID: 1807401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bovine serum albumin (BSA) nephritis in rats II. Histological findings and complement activation by immune complex in SHR rats.
    Yamamoto T; Kihara I; Hara M; Kawasaki K; Yaoita E
    Br J Exp Pathol; 1983 Dec; 64(6):660-9. PubMed ID: 6661397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exaggerated glomerular albuminuria after cobra venom factor in anti-glomerular basement membrane disease.
    Savige JA; Dash AC; Rees AJ
    Nephron; 1989; 52(1):29-35. PubMed ID: 2523520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.